Login to Your Account



Dengue Returns to U.S.

Biotechs Boost Dengue Efforts Amid New Mechanistic Insights

By Trista Morrison


Monday, July 26, 2010
After a 65-year absence, the dengue virus has reemerged in the continental U.S., shining a spotlight on new research into the mechanisms behind severe dengue hemorrhagic fever as well as pharma and biotech efforts to develop a dengue vaccine.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription